Long-Term Outcomes of Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Use Among Patients on Maintenance Dialysis
Pun P, Qin L, Minges K, Al-Khatib S, Friedman D. Long-Term Outcomes of Subcutaneous Versus Transvenous Implantable Cardioverter Defibrillator Use Among Patients on Maintenance Dialysis. Heart Rhythm 2024 PMID: 39615818, DOI: 10.1016/j.hrthm.2024.11.050.Peer-Reviewed Original ResearchHospital admissionAccess interventionsAssociated with decreased riskFee-for-serviceLongitudinal cohort studyMedicare claims dataAssociated with decreased risk of deathImplantable cardioverter defibrillator useNational Cardiovascular Data Registry ICD RegistryBurden of cardiac diseaseRisk of deathDialysis access interventionsDefibrillator useClaims dataElevated risk of sudden cardiac deathImplantable cardioverter defibrillatorLong-term outcomesRisk of sudden cardiac deathStabilized inverse probabilityDialysis patientsElevated riskInclusion criteriaTV-ICDS-ICDICD Registry